Caffeic-acid

Product of hydrolysis by Faec and inhibitor of some a/b hydrolases. Caffeic Acid is an orally bioavailable, hydroxycinnamic acid derivative and polyphenol, A member of catechols, with potential anti-oxidant, anti-inflammatory, and antineoplastic activities. It has a role as a plant metabolite, an EC 1.13.11.33 (arachidonate 15-lipoxygenase) inhibitor, an EC 2.5.1.18 (glutathione transferase) inhibitor, an EC 1.13.11.34 (arachidonate 5-lipoxygenase) inhibitor, an antioxidant and an EC 3.5.1.98 (histone deacetylase) inhibitor.

General

Type : Hydroxycinnamic-ester, Acrylate

Chemical_Nomenclature : (E)-3-(3,4-dihydroxyphenyl)prop-2-enoic acid

Canonical SMILES : C1=CC(=C(C=C1C=CC(=O)O)O)O

InChI : InChI=1S\/C9H8O4\/c10-7-3-1-6(5-8(7)11)2-4-9(12)13\/h1-5,10-11H,(H,12,13)\/b4-2+

InChIKey : QAIPRVGONGVQAS-DUXPYHPUSA-N

Other name(s) : Caffeic acid  ||  3,4-Dihydroxycinnamic acid  ||  331-39-5  ||  3-(3,4-dihydroxyphenyl)acrylic acid  ||  Trans-Caffeate  ||  DB01880  ||  CHEBI:16433  ||  CHEBI:36281  ||  CHEMBL145


MW : 180.15

Formula : C9H8O4

CAS_number : 501-16-6

PubChem : 689043

UniChem : QAIPRVGONGVQAS-DUXPYHPUSA-N

Target

Families : Caffeic-acid ligand of proteins in family
FAE-Bacterial-promiscuous

Structure :
3S2Z

Protein :
lacjo-q74hk5

References (2)

Title : Modulatory effect of caffeic acid on cholinesterases inhibitory properties of donepezil - Agunloye_2017_J.Complement.Integr.Med_15_
Author(s) : Agunloye OM , Oboh G
Ref : J Complement Integr Med , 15 : , 2017
Abstract :
PubMedSearch : Agunloye_2017_J.Complement.Integr.Med_15_
PubMedID: 28941354

Title : An inserted alpha\/beta subdomain shapes the catalytic pocket of Lactobacillus johnsonii cinnamoyl esterase - Lai_2011_PLoS.One_6_e23269
Author(s) : Lai KK , Stogios PJ , Vu C , Xu X , Cui H , Molloy S , Savchenko A , Yakunin A , Gonzalez CF
Ref : PLoS ONE , 6 :e23269 , 2011
Abstract :
PubMedSearch : Lai_2011_PLoS.One_6_e23269
PubMedID: 21876742
Gene_locus related to this paper: lacjo-q74hk5